Citations

Mayo Clinic

Showing 10 of 108523 citations.

Results of a phase 2 study of pacritinib (SB1518), a JAK2/JAK2(V617F) inhibitor, in patients with myelofibrosis
Komrokji, Rami S. , Seymour, John F. , Roberts, Andrew W. , Wadleigh, Martha , To, Luen Bik, Scherber, Robyn M. , Turba, E , Dorr, Andrew, Zhu, Joy, Wang, Lixia , Granston, Tanya, Campbell, Mary S., Scherber, Robyn, Mesa, Ruben A. , Roberts, Andrew W , Komrokji, Rami S

Blood | March 11, 2015 | Volume: 125 | Issue: 17 | Pages: 2649-2655

10.1182/blood-2013-02-484832 | PMID 25762180 Get It

Key Points Pacritinib reduced myelofibrosis-related splenomegaly and patient symptoms without causing clinically significant myelosuppression. Pacritinib had activity and was well tolerated in patients with preexisting anemia and thrombocytopenia.
HkRP3 Is a Microtubule-Binding Protein Regulating Lytic Granule Clustering and NK Cell Killing
Ham, Hyoungjun , Huynh, Walter , Schoon, Renee A., Vale, Ronald D. , Billadeau, Daniel D.

The Journal of Immunology | March 11, 2015 | Volume: 194 | Issue: 8 | Pages: 3984-3996

10.4049/jimmunol.1402897 | PMID 25762780 Get It

Abstract NK cells provide host defense by killing viral-infected and cancerous cells through the secretion of preformed lytic granules. Polarization of the lytic granules toward the target cell is dependent on an intact microtubule (MT) network as well as MT motors. We have recently shown that DOCK8, a gene mutated in a primary immunodeficiency syndrome, is involved in NK cell killing in part through its effects on MT organizing center (MTOC) polarization. In this study, we identified Hook-related protein 3 (HkRP3) as a novel DOCK8- and MT-binding protein. We further show that HkRP3 is present in lytic granule fractions and interacts with the dynein motor complex and MTs. Significantly, depletion of HkPR3 impaired NK cell cytotoxicity, which could be attributed to a defect in not only MTOC polarity, but also impaired clustering of lytic granules around the MTOC. Our results demonstrate an important role for HkRP3 in regulating the clustering of lytic granules and MTOC repositioning during the development of NK cell–mediated killing.
Outcome After Therapeutic Hypothermia in Term Neonates With Encephalopathy and a Syndromic Diagnosis
Mrelashvili, Anna, Bonifacio, Sonia L. , Rogers, Elizabeth E. , Shimotake, Thomas K., Glass, Hannah C.

Journal of Child Neurology | March 11, 2015 | Volume: 30 | Issue: 11 | Pages: 1453-1458

10.1177/0883073815569307 | PMID 25762585 Get It

The large randomized, controlled trials of therapeutic hypothermia for hypoxic-ischemic encephalopathy excluded neonates with congenital disorders. The objective of this study was to report our experience using hypothermia in neonates with signs of hypoxic-ischemic encephalopathy and a syndromic disorder or brain anomaly. Subjects were identified from a database of neonates admitted to the Neuro-Intensive Care Nursery at University of California, San Francisco. Of 169 patients fulfilling criteria for hypothermia, 8 (5%) had a syndromic disorder and were cooled per guidelines for nonsyndromic neonates. Perinatal characteristics of infants with and without syndromic disorder were not significantly different. Overall outcome was poor: 38% had evidence of acute hypoxic-ischemic injury, 3 subjects died, and 2 survivors had low developmental quotient (ie, 25). The risk versus benefit of therapeutic hypothermia for hypoxic-ischemic encephalopathy among neonates with congenital brain malformations or syndromic diagnoses is uncertain.
Covert tricuspid valve rupture secondary to blunt chest trauma
Moustafa, Sherif, Ejaz, Nauman, Shah, Parth

Asian Cardiovascular and Thoracic Annals | March 11, 2015 | Volume: 24 | Issue: 6 | Pages: 607-608

10.1177/0218492315575946 | PMID 25762079 Get It

Ever-expanding Clinical Implications of Qt Interval Prolongation
O’Hare, Meabh, Mookadam, Farouk , Ramakrishna, Harish , Mookadam, Farouk

Future Cardiology | March 11, 2015 | Volume: 11 | Issue: 2 | Pages: 133-135

10.2217/fca.15.6 | PMID 25760872 Get It

Letter to the Editor
Lynde, Carrie B., Bruce, Alison J., Murray, Joseph A. , Rogers, Roy S., Murray, J A

Journal of Cutaneous Medicine and Surgery | March 11, 2015 | Volume: 13 | Issue: 1 | Pages: 53-54

10.2310/7750.2008.07086 | PMID 19298774 Get It

Impact of Utilizing a Women-Based Formula for Determining Adequacy of the Chronotropic Response During Exercise Treadmill Testing
Gulati, Martha , Pack, Quinn R. , Barr, Laurie, Allison, Thomas G. , Abdelmoneim, Sahar S. , Mulvagh, Sharon L. , Scott, Christopher G.

Journal of Women's Health | March 11, 2015 | Volume: 24 | Issue: 3 | Pages: 174-181

10.1089/jwh.2014.4935 | PMID 25761214 Get It

Background: A women-based formula for calculation of age-predicted maximum heart rate [age-predicted maximum heart rate=206−(0.88×age)] was established in asymptomatic volunteer women undergoing treadmill exercise tolerance testing (ETT). We sought to perform a comparison of the performance of this women-based formula for prediction of peak heart rate to the traditional formula [220−age] and our own database-generated prediction formula in a large database of women undergoing ETT. Methods: We performed a retrospective analysis of all consecutive women who underwent symptom-limited Bruce protocol ETT at the Mayo Clinic from 1994 to 2010. Women with known cardiovascular disease or those using beta blockers, calcium channel blockers, or digitalis were excluded. Separate analyses were performed according to symptomatic status. Results: The study included 11,029 women (89.4% Caucasian) with a mean age 52±12 years; 3,632 (33%) were referred specifically for evaluation of symptoms. Age-predicted maximum heart rate calculated by the traditional formula was achieved by 49.7% of women versus 69.9% by the women-based formula with most of the underestimation observed in older women. Average absolute deviation between achieved and predicted peak heart rate (HR) was 10.85±9.18 bpm for traditional versus 11.98±9.00 for women-based formulas (dependent t =−16.64, p <0.0001). The linear regression line calculated from our population [HR=201−(0.67×age)] was closer to the women-based formula, both in terms of intercept and slope than the traditional formula. Peak HR was shown to be slightly affected (−2.5 bpm) by symptom status at referral, whereas smoking and diabetes more significantly reduced achieved peak HR. Conclusions: The women-based formula underestimated peak HR, especially in older women, but was observed to be closer in both intercept and slope to the regression line determined from our study in this large population of female patients. These sex-unique observations should be taken into account when determining adequacy and targets for ETT in women.
Newborn screening for homocystinurias and methylation disorders: systematic review and proposed guidelines
Huemer, Martina , Kožich, Viktor , Rinaldo, Piero, Baumgartner, Matthias R. , Merinero, B., Pasquini, Elisabetta , Ribes, Antònia , Blom, Henk J. , Ribes, Antonia , Baumgartner, Matthias

Journal of Inherited Metabolic Disease | March 11, 2015 | Volume: 38 | Issue: 6 | Pages: 1007-1019

10.1007/s10545-015-9830-z | PMID 25762406 Get It

AbstractNewborn screening (NBS) is justified if early intervention is effective in a disorder generally not detected early in life on a clinical basis, and if sensitive and specific biochemical markers exist. Experience with NBS for homocystinurias and methylation disorders is limited. However, there is robust evidence for the success of early treatment with diet, betaine and/or pyridoxine for CBS deficiency and good evidence for the success of early betaine treatment in severe MTHFR deficiency. These conditions can be screened in dried blood spots by determining methionine (Met), methionine‐to‐phenylanine (Met/Phe) ratio, and total homocysteine (tHcy) as a second tier marker. Therefore, we recommend NBS for cystathionine beta‐synthase and severe MTHFR deficiency. Weaker evidence is available for the disorders of intracellular cobalamin metabolism. Early treatment is clearly of advantage for patients with the late‐onset cblC defect. In the early‐onset type, survival and non‐neurological symptoms improve but the effect on neurocognitive development is uncertain. The cblC defect can be screened by measuring propionylcarnitine, propionylcarnitine‐to‐acetylcarnitine ratio combined with the second tier markers methylmalonic acid and tHcy. For the cblE and cblG defects, evidence for the benefit of early treatment is weaker; and data on performance of Met, Met/Phe and tHcy even more limited. Individuals homozygous or compound heterozygous for MAT1A mutations may benefit from detection by NBS using Met, which on the other hand also detects asymptomatic heterozygotes. Clinical and laboratory data is insufficient to develop any recommendation on NBS for the cblD, cblF, cblJ defects, glycineN‐methyltransferase‐, S‐adenosylhomocysteinehydrolase‐ and adenosine kinase deficiency.
Measurement of psychosine in dried blood spots — a possible improvement to newborn screening programs for Krabbe disease
Turgeon, Coleman , Orsini, Joseph J. , Sanders, Karen A., Magera, Mark J , Langan, Thomas J. , Escolar, Maria L. , Duffner, Patricia K., Oglesbee, Devin , Gavrilov, Dimitar , Tortorelli, Silvia , Rinaldo, Piero, Raymond, Kimiyo , Matern, Dietrich , Turgeon, Coleman T, Oglesbee, Devin

Journal of Inherited Metabolic Disease | March 11, 2015 | Volume: 38 | Issue: 5 | Pages: 923-929

10.1007/s10545-015-9822-z | PMID 25762404 Get It

AbstractBackgroundNewborn screening (NBS) for Krabbe disease (KD) in New York and Missouri is conducted by measuring galactocerebrosidase (GALC) activity using tandem mass spectrometry (MS/MS). These NBS efforts have shown that the incidence of KD is unexpectedly low (1:400,000) while many individuals (ca. 1:6000) with reduced GALC activity and genotypes of uncertain significance are detected and subjected to follow up testing. Psychosine (PSY) is a putative marker of KD progression and can be measured in dried blood spots (DBS). We sought to determine the role that PSY levels play in NBS for KD, follow up, and treatment monitoring.MethodsPSY was eluted from DBS with methanol containing N,N‐dimethyl‐D‐erythro‐sphingosine as internal standard (IS). Liquid chromatography‐MS/MS was conducted over 17 minutes in the multiple reaction monitoring positive mode to follow the precursor to product species transitions for PSY and IS. Separation of the structural isomers PSY and glucosylsphingosine was accomplished by hydrophilic interaction liquid chromatography.ResultsPre‐analytical and analytical factors were studied and revealed satisfactory results. PSY was also measured in DBS collected from controls (range: <8 nmol/L, N = 220), KD patients at various disease stages (range: 8–112, N = 26), and GALC mutation carriers (range: <15 nmol/L, N = 18).ConclusionsPSY measurement in DBS could serve as a 2nd tier assay in NBS for KD, simplify and reduce the cost of follow up protocols, help determine disease progression, and be used to monitor KD patients following hematopoietic stem cell transplantation. However, additional chronological measurements of PSY in KD patients are required to confirm these possibilities.
Dual roles of autologous CD8+ T cells in hematopoietic progenitor cell mobilization and engraftment
Russell, Athena , Malik, Sunita , Litzow, Mark R. , Gastineau, Dennis A., Gastineau, Dennis, Gastineau, Dennis A. , Roy, Vivek , Zubair, Abba C.

Transfusion | March 11, 2015 | Volume: 55 | Issue: 7 | Pages: 1758-1765

10.1111/trf.13073 | PMID 25757596 Get It

BACKGROUNDPoor marrow cellularity alone cannot explain poor hematopoietic progenitor cell (HPC) mobilization. This study assessed the role of CD8+ T cells in HPC cell mobilization and engraftment.STUDY DESIGN AND METHODSMobilization and engraftment were assessed in 192 autologous HPC donors. CD34+, CD4+, and CD8+ T‐cell contents in apheresis products were evaluated. Using a chemotaxis assay, we assessed the effect of purified autologous CD8+ T cells from low and high mobilizers on HPC migration from high to low stromal cell–derived factor (SDF‐1α) concentration gradients. We also assessed CD8+ T‐cell content association with days to neutrophil engraftment.RESULTSThe median number of CD34+ cells/kg was 4.7 × 106. Patients were categorized according to their total CD34+ cell collection quartile distribution into low, moderate, and high mobilizers. We found that HPC products from low mobilizers contained more CD8+ T cells than HPC products from moderate and high mobilizers. Chemotaxis assays showed depletion of CD8+ T cells enhances HPC mobilization independent of SDF‐1α concentration. Neutrophil engraftment analysis showed that the higher the CD8+ T‐cell content per unit CD34+ cell, the faster the rate of engraftment.CONCLUSIONOur findings suggest CD8+ T cells inhibit HPC mobilization and facilitate homing and engraftment.